About

Wanda Phipatanakul headshot

Director, Clinical Research Center, Boston Children's Hospital and S. Jean Emans Professor of Pediatrics, Dr. Wanda Phipatanakul

Wanda Phipatanakul, MD, MS has dedicated her career to clinical research focused on reducing and preventing asthma and allergic diseases in children, particularly inner-city children who often face disproportionate rates of asthma and allergies. In addition to her role as Director of the Clinical Research Center in the Division of Asthma, Allergy, Dermatology, Rheumatology, and Immunology at Boston Children’s Hospital, Dr. Phipatanakul is the S. Jean Emans Professor of Pediatrics at Harvard Medical School. She is currently ranked in the top 5 among world asthma experts in impact in the past decade.

Dr. Phipatanakul has authored >450 of publications in scientific journals, including JAMA and the New England Journal of Medicine. She takes great pride in translating her research findings into actionable ways to improve care for her patients and providing mentorship for the next generation of scientific investigators.

Read Dr. Phipatanakul’s Publications

Dr. Phipatanakul’s Google Scholar

Dr. Phipatanakul’s Harvard Catalyst Profile

World Asthma Expert Rankings

Boston Children's Hospital logo

Boston Children’s Hospital

The research consortium at Boston Children’s Hospital consists of over 3,000 researchers. As such, it is the world’s largest research enterprise at a pediatric center. With over a million square feet of research space, $423 million in annual research funding, and more than 100 new inventions each year, Boston Children’s Hospital researchers have the people and resources to better understand disease biology, expand the knowledge of rare diseases, and improve health outcomes across the board.

National Institutes of Health logo

National Institutes of Health

NIH is part of the U.S. Department of Health and Human Services. It is the largest biomedical research agency in the world. NIH works with Clinical Research Center on a number of studies to reduce the severity of asthma and allergies in the population and improve quality of life, and therefore, life expectancies.